Abstract
Objectives: MitraClip (MC) implantation has become a widely accepted therapeutic option in the treatment of severe mitral regurgitation (MR) in patients unsuitable for surgery. N-terminal B-type natriuretic peptide (NT-proBNP), a biomarker released in the ventricular wall reflecting excessive mechanical stress, is routinely used as a prognostic variable in the setting of heart failure therapy. We sought to evaluate the impact of acute post-procedural changes in NT-proBNP on clinical outcome after successful MC therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
